Abstracts

IMMUNOGENICITY OF SARS-CoV-2 mRNA VACCINATION IN IDIOPATHIC CD4 LYMPHOPENIA

Background: The rapid development of SARS-CoV-2 mRNA vaccines has been a remarkable success of the COVID-19 pandemic, but vaccine-induced immunity is heterogeneous in immunocompromised populations. We sought to determine the immunogenicity of SARS-CoV-2 mRNA vaccines in a cohort of people with idiopathic CD4 lymphopenia (ICL). Methods: 25-patients with ICL followed at the National Institutes of…

ADEQUATE DTG EXPOSURE IN INFANTS ON RIFAMPICIN TREATMENT RECEIVING TWICE-DAILY DTG

Background: Dolutegravir (DTG) is recommended by WHO as first-line treatment option for children living with HIV. Rifampicin (RIF) interacts substantially with DTG by increasing DTG metabolism through induction of UGT1A1 and CYP3A4, thereby reducing its exposure resulting in potential treatment failure. Adapting the DTG dosing interval from once-daily (OD) to twice-daily (BID) was safe and…

PREDICTIVE VALIDITY OF A MEASURE OF BARRIERS TO ART ADHERENCE FOR HIV CARE (I-SCORE)

Background: It is recommended to identify and address adherence barriers to antiretroviral therapy (ART) in routine HIV care. From a conceptual framework, we created a 7-item patient-reported measure (Interference-Score) to evaluate seven barrier domains (i.e. Thoughts/Feelings, Habits/Activities, Social situation, Economic status, Medication, Care, and Health). Both English and French versions were produced with stakeholder engagement…

IMMUNE ACTIVATION AND NEUROCOGNITION IN UGANDAN ADOLESCENTS LIVING WITH HIV

Background: Immune activation is associated with neurocognitive problems in virally suppressed adults living with HIV. Less is known about this relationship in adolescents with perinatally acquired HIV (PHIV) residing in low-income countries with high burdens of PHIV. We examined this relationship in Ugandan adolescents with PHIV. Methods: Eighty-two adolescents in Kampala, Uganda (28 virally suppressed…

ANGIOGENIC BIOMARKERS OF POOR OUTCOMES IN PREGNANT WOMEN WITH HIV IN BOTSWANA

Background: The Botswana-based Tsepamo study identified associations between dolutegravir (DTG)-containing antiretroviral therapy (ART) regimens initiated prior to conception and maternal hypertension (HTN) and infants born small for gestational age (SGA) using a comparison group of HIV-seronegative pregnant women and their infants. Early biomarkers of poor pregnancy outcomes to detect and intervene on pregnancies at elevated…